Orthostatic Hypotension May Increase Risk of Dementia

Share this content:
Orthostatic Hypotension May Increase Risk of Dementia
Orthostatic Hypotension May Increase Risk of Dementia

WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- There is an association between orthostatic hypotension and an increased risk for dementia, according to a new study published online Oct. 11 in PLOS Medicine.

Frank Wolters, M.D., of the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues analyzed 24 years of data from 6,204 people.

The researchers found that orthostatic hypotension was associated with a 15 percent increase in long-term risk of dementia, including Alzheimer's disease. Furthermore, the risk was particularly increased when the orthostatic blood pressure drops were not compensated for by a sufficient increase in heart rate.

"The most apparent explanation for our findings is that orthostatic hypotension causes brain damage due to recurrent transient cerebral hypoperfusion," the authors write. "Autonomic nervous system function is responsible for maintaining continuous cerebral perfusion, together with local vasoreactivity, which has previously been associated with the risk of dementia in the general population. Brief episodes of hypoperfusion elicited by sudden blood pressure drops may lead to hypoxia, with detrimental effects on brain tissue via, for instance, neuroinflammation and oxidative stress."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Post-Deployment Screening Has Limited Benefit in U.K. Military

Post-Deployment Screening Has Limited Benefit in U.K. Military

Screening based on tailored advice does not reduce prevalence of disorders or increase help-seeking

Excess BMI Ups Risk of T1DM in Autoantibody-Positive Relatives

Excess BMI Ups Risk of T1DM in Autoantibody-Positive ...

Increased diabetes progression risk occurred at lower cumulative excess BMI index in children <12

Baricitinib Associated With Significant Improvement in RA

Baricitinib Associated With Significant Improvement in RA

Findings versus placebo, adalimumab in patients non-responsive to methotrexate

is free, fast, and customized just for you!

Already a member?

Sign In Now »